C4 Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover C4 Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $12.2, which forecasts a 284.86% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $30.

Price Target: $12.2 (+284.86%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$12.2	$8.00	$30
Change	+89.27%	+284.86%	+152.37%	+846.37%

* Price targets were last updated on Feb 27, 2026.

Analyst Ratings

The average analyst rating for C4 Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	3	3	3	3
Buy	3	3	3	3	3	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Etzer Darout Barclays	Barclays	Buy Maintains $5 → $7	Buy	Maintains	$5 → $7	+120.82%	Feb 27, 2026
Leah Rush Brookline Capital	Brookline Capital	Strong Buy Maintains $20 → $30	Strong Buy	Maintains	$20 → $30	+846.37%	Feb 23, 2026
Etzer Darout Barclays	Barclays	Buy Maintains $10 → $5	Buy	Maintains	$10 → $5	+57.73%	Dec 17, 2025
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Dec 2, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $5 → $10	Buy	Maintains	$5 → $10	+215.46%	Sep 23, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

21.57M

from 35.95M

-40.01%

from 35.95M

Revenue Next Year

20.79M

from 21.57M

-3.58%

from 21.57M

EPS This Year

-1.48

from -1.27

EPS Next Year

-1.08

from -1.48

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	45.79M	31.10M	20.76M	35.58M	35.95M	21.57M	20.79M
Revenue Growth	37.93%	-32.08%	-33.25%	71.44%	1.02%	-40.01%	-3.58%
EPS	-1.82	-2.62	-2.67	-1.52	-1.27	-1.48	-1.08
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	42.0M	31.2M
Avg	21.6M	20.8M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	16.8%	44.6%
Avg	-40.0%	-3.6%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.82	-0.71
Avg	-1.48	-1.08
Low	-3.68	-1.41

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.